Sign In
Buy AXGN
$42.21
+0.86 (+2.08%)
At Close: Jul 31, 2026
AxoGen (NASDAQ:AXGN) Shares Gap Down Following Weak Earnings
02:01am, Thursday, 30'th Jul 2026
AxoGen, Inc. (NASDAQ: AXGN - Get Free Report)'s stock price gapped down prior to trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously clos
Axogen, Inc. (AXGN) Q2 2026 Earnings Call Transcript
02:43pm, Wednesday, 29'th Jul 2026
Axogen, Inc. (AXGN) Q2 2026 Earnings Call Transcript
AxoGen Q2 Earnings Call Highlights
10:05am, Wednesday, 29'th Jul 2026
AxoGen NASDAQ: AXGN reported second-quarter 2026 revenue of $69.7 million, up 23.1% from a year earlier, as demand for its Avance nerve graft and broader product portfolio increased across its target
AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates
09:26am, Wednesday, 29'th Jul 2026
AxoGen (AXGN) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.12 per share a year ago.
/PRNewswire/ -- Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced it has received a
Axogen, Inc. Reports Second Quarter 2026 Financial Results
07:05am, Wednesday, 29'th Jul 2026
ALACHUA, Fla. and TAMPA, Fla.
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026
07:00am, Wednesday, 15'th Jul 2026
ALACHUA, Fla. and TAMPA, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of periphera
AxoGen, Stock Of The Day, Offers Entry After Bullish Rebound
02:25pm, Friday, 05'th Jun 2026
AxoGen, Stock Of the Day, is flashing a buy signal. Ten out of 10 analysts are bullish about AxoGen after strong earnings and raised 2026 guidance.
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam
11:07am, Thursday, 14'th May 2026
AxoGen NASDAQ: AXGN President and CEO Michael Dale said the company's growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are expecte
Axogen, Inc. (AXGN) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
06:00pm, Wednesday, 13'th May 2026
Axogen, Inc. (AXGN) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
07:00am, Thursday, 30'th Apr 2026
ALACHUA, Fla. and TAMPA, Fla.
Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript
05:41pm, Tuesday, 28'th Apr 2026
Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript
AxoGen (AXGN) Q1 Earnings Lag Estimates
09:16am, Tuesday, 28'th Apr 2026
AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.02 per share a year ago.
Axogen, Inc. Reports First Quarter 2026 Financial Results
07:00am, Tuesday, 28'th Apr 2026
ALACHUA, Fla. and TAMPA, Fla.
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million
10:38am, Sunday, 26'th Apr 2026
This healthcare firm develops nerve repair solutions for hospitals and specialists in the U.S. and select global markets.
